BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24039899)

  • 1. Relationship between the use of inhaled steroids for chronic respiratory diseases and early outcomes in community-acquired pneumonia.
    Almirall J; Bolíbar I; Serra-Prat M; Palomera E; Roig J; Hospital I; Carandell E; Agustí M; Ayuso P; Estela A; Torres A;
    PLoS One; 2013; 8(9):e73271. PubMed ID: 24039899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled drugs as risk factors for community-acquired pneumonia.
    Almirall J; Bolíbar I; Serra-Prat M; Palomera E; Roig J; Hospital I; Carandell E; Agustí M; Ayuso P; Estela A; Torres A;
    Eur Respir J; 2010 Nov; 36(5):1080-7. PubMed ID: 20525710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled corticosteroids and systemic inflammatory response in community-acquired pneumonia: a prospective clinical study.
    Ferrer M; Torres A; Martínez R; Ramírez P; Polverino E; Montull B; Sialer S; Niederman MS; Agusti A; Menéndez R
    Respirology; 2014 Aug; 19(6):929-35. PubMed ID: 24909304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features, etiology and outcomes of community-acquired pneumonia in patients with chronic obstructive pulmonary disease.
    Gómez-Junyent J; Garcia-Vidal C; Viasus D; Millat-Martínez P; Simonetti A; Santos MS; Ardanuy C; Dorca J; Carratalà J
    PLoS One; 2014; 9(8):e105854. PubMed ID: 25166349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic obstructive pulmonary disease and mortality from pneumonia: meta-analysis.
    Loke YK; Kwok CS; Wong JM; Sankaran P; Myint PK
    Int J Clin Pract; 2013 May; 67(5):477-87. PubMed ID: 23574107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severity and outcomes of community acquired pneumonia in asthmatic patients.
    Terraneo S; Polverino E; Cilloniz C; Amaro R; Vennera Mdel C; Gabarrus A; Montull B; Moreno E; Menendez R; Centanni S; Torres A
    Respir Med; 2014 Nov; 108(11):1713-22. PubMed ID: 25245791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic inflammatory pattern of patients with community-acquired pneumonia with and without COPD.
    Crisafulli E; Menéndez R; Huerta A; Martinez R; Montull B; Clini E; Torres A
    Chest; 2013 Apr; 143(4):1009-1017. PubMed ID: 23187314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influence of initial protocolized treatment with steroids in length of stay and costs of community acquired pneumonia].
    Gómez Gómez J; Gómez Torres JL; Hernández Torres A; García Córdoba JA; Canteras Jordana M
    Rev Esp Quimioter; 2017 Oct; 30(5):350-354. PubMed ID: 28737025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of roflumilast as an add-on to triple inhaled therapy vs triple inhaled therapy in patients with severe and very severe COPD associated with chronic bronchitis in the UK.
    Kiff C; Ruiz S; Varol N; Gibson D; Davies A; Purkayastha D
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2707-2720. PubMed ID: 30214188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased risk of community-acquired pneumonia in COPD patients with comorbid cardiovascular disease.
    Lin SH; Perng DW; Chen CP; Chai WH; Yeh CS; Kor CT; Cheng SL; Chen JJ; Lin CH
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3051-3058. PubMed ID: 27980402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seasonality, risk factors and burden of community-acquired pneumonia in COPD patients: a population database study using linked health care records.
    Williams NP; Coombs NA; Johnson MJ; Josephs LK; Rigge LA; Staples KJ; Thomas M; Wilkinson TM
    Int J Chron Obstruct Pulmon Dis; 2017; 12():313-322. PubMed ID: 28176888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The outcome of community-acquired pneumonia in patients with chronic lung disease: a case-control study.
    Dusemund F; Chronis J; Baty F; Albrich WC; Brutsche MH
    Swiss Med Wkly; 2014; 144():w14013. PubMed ID: 25184329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in hospitalized community-acquired pneumonia: a retrospective study of a prospective observational cohort.
    Ito A; Ishida T; Tokumasu H; Washio Y; Yamazaki A; Ito Y; Tachibana H
    BMC Pulm Med; 2017 May; 17(1):78. PubMed ID: 28464807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prehospital use of inhaled corticosteroids and point prevalence of pneumonia at the time of hospital admission: secondary analysis of a multicenter cohort study.
    Festic E; Bansal V; Gajic O; Lee AS;
    Mayo Clin Proc; 2014 Feb; 89(2):154-62. PubMed ID: 24485129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Community-acquired pneumonia in patients with chronic obstructive pulmonary disease treated with inhaled corticosteroids or other bronchodilators. Study PNEUMOCORT].
    Morros R; Vedia C; Giner-Soriano M; Casellas A; Amado E; Baena JM;
    Aten Primaria; 2019; 51(6):333-340. PubMed ID: 29661670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of inhaled corticosteroids on community-acquired pneumonia in patients with bronchial asthma.
    To M; To Y; Yamada H; Ogawa C; Otomo M; Suzuki N; Sano Y
    Intern Med; 2004 Aug; 43(8):674-8. PubMed ID: 15468964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pneumonic and nonpneumonic exacerbations of COPD: inflammatory response and clinical characteristics.
    Huerta A; Crisafulli E; Menéndez R; Martínez R; Soler N; Guerrero M; Montull B; Torres A
    Chest; 2013 Oct; 144(4):1134-1142. PubMed ID: 23828375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of steroids on procalcitonin and C-reactive protein in patients with COPD and community-acquired pneumonia.
    Perren A; Cerutti B; Lepori M; Senn V; Capelli B; Duchini F; Domenighetti G
    Infection; 2008 Mar; 36(2):163-6. PubMed ID: 18330505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of exacerbation following pneumonia in adults with heart failure or chronic obstructive pulmonary disease.
    Bornheimer R; Shea KM; Sato R; Weycker D; Pelton SI
    PLoS One; 2017; 12(10):e0184877. PubMed ID: 29028810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and Safety of Inhaled Corticosteroids in Older Individuals with Chronic Obstructive Pulmonary Disease and/or Asthma. A Population Study.
    Kendzerska T; Aaron SD; To T; Licskai C; Stanbrook M; Vozoris NT; Hogan ME; Tan WC; Bourbeau J; Gershon AS
    Ann Am Thorac Soc; 2019 Oct; 16(10):1252-1262. PubMed ID: 31298938
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.